(b)(4).Additional information, including post primary and pre revision x-rays, operative notes, patient age and activity level, a detailed patient outcome and the explanted devices has been requested in order to progress with this investigation, and if received, will be provided in a supplemental report upon completion of this investigation.The appropriate device details have been provided and the relevant device manufacturing records will be identified and reviewed.Please note: this report is filed with the fda due to an adverse event experienced with a device that is similar to those placed on the market in the usa, however, this event occurred outside of the usa.
|
(b)(4) final report.Additional information, including post primary and pre revision x-rays, operative notes, patient age and activity level, a detailed patient outcome and the explanted devices was requested in order to progress with this investigation.However, none were available and thus there was only very limited information available for the investigation.The explants were discarded by the hospital following the revision and thus could not be examined.The appropriate device details were provided and the relevant device manufacturing records have been identified and reviewed.All finished parts associated with these records conformed to material and dimensional specification at the time of manufacture.From the information provided in the report to corin, it appears that despite the addition of three screws, the cup did not achieve primary fixation through adequate press-fit with the acetabulum leading to loosening/movement of the cup.The surgeon has also commented that he believes the movement/loosening of the cup could be due to a fracture of the patient's pelvis which healed.Based on the information available, no further investigation can be conducted and thus corin now consider this case closed.However, should any additional information be provided, then this case may be re-opened for further investigation.Please note: this report is filed with the fda due to an adverse event experienced with a device that is similar to those placed on the market in the usa, however, this event occurred outside of the usa.
|